… or a comparator vaccine to 6537 infants who were 6 to 12 weeks of age at the time of the
first vaccination in conjunction with Expanded Program on Immunization (EPI) vaccines in a …

… malaria vaccine is considered a further important step towards reducing the disease burden.
RTS,S/AS01 is a malaria vaccine … infants aged 6–12 weeks at first vaccination demonstrated …

… malaria in HIV-infected children. Based on these data, we see no reason why the RTS,S/AS01
vaccine would be contraindicated in infants … non-replicating, recombinant vaccines [38]. …

… malaria burden among young infants in sub-Saharan Africa, a malaria vaccine should be given
in early infancy … During this period, routine vaccines are administered to infants according …

… malaria vaccine, which is being developed for infants and children in regions in sub-Saharan
Africa in which malaria is … prevention of malaria, which occurs in infants who have reached …

… this advance in malaria control. Moreover, additional interventions—specifically, … malaria
vaccines—will be needed to eliminate malaria in the large areas of Africa where malaria …

Background The efficacy and safety of the RTS,S/AS01 candidate malaria vaccine during 18
months of follow-up have been published previously. Herein, we report the final results from …

… Malaria vaccine development has rapidly advanced in the past decade. The very first
phase 3 clinical trial of the RTS,S vaccine was completed with over 15,000 African infants and …

… is being implemented may hamper the assessment of vaccine safety and … , malaria,
mortality, and other health outcomes prior to vaccine introduction through the Malaria Vaccine …

… Ankara (MVA), with highest responses in infants aged 10 weeks at priming. Incorporating …
infants, supporting future evaluation of efficacy in this key target age group for a malaria vaccine…